Table 1.
Patient donor information.
| Diagnosis | Sex | Age | PMI (hours) | FMR1 repeats |
|---|---|---|---|---|
| Control | F | 82 | 21 | n.d. |
| Control | M | 39 | 22 | n.d. |
| Control | M | 47 | 23 | n.d. |
| Control | M | 69 | 24 | n.d. |
| Control | M | 72 | 23 | n.d. |
| Control | F | 86 | 18 | n.d. |
| Control | F | 87 | 9 | n.d. |
| Control | F | 74 | 6 | n.d. |
| Control | M | 59 | 12 | n.d. |
| Control | M | 81 | 6 | n.d. |
| AD | F | 78 | 2 | n.d. |
| AD | M | 69 | 12 | n.d. |
| AD | F | 75 | 24 | n.d. |
| AD | F | 66 | 9 | n.d. |
| AD | M | 82 | 9 | n.d. |
| AD | M | 73 | 3 | n.d. |
| AD | F | 86 | 15 | n.d. |
| AD | M | 80 | 21 | n.d. |
| AD | F | 75 | 24 | n.d. |
| AD | M | 69 | 13 | n.d. |
| FXTAS | M | 78 | 3.5 | 90 CGGs |
| FXTAS | M | 74 | 3 | 102 CGGs |
| FXTAS | M | 80 | 6.5 | 116 blood/180 cheek |
Diagnosis, age at death, post-mortem interval (PMI) in hours for all patients, and FMR1 5′ UTR CGG length for FXTAS patients included above. n.d. indicates not determined.